Empowering Community Pharmacies: myphysician360 and KARE PharmTech Announce Strategic Partnership

December 6, 2024 11:45 AM

myphysician360, a leader in digital health innovation serving rural communities, proudly announces a groundbreaking partnership with KARE PharmTech. Together, the two organizations aim to establish the largest connected network of independent pharmacies in the United States. This collaboration integrates cutting-edge telemedicine technology into local pharmacies, enhancing access to primary and urgent care while reinforcing their critical role...

Read more

Microblading PMU Removal Services Now Available at Skin & Laser Dermatology Center

December 6, 2024 11:00 AM

Dr. Amir Bajoghli and Skin & Laser Dermatology Center are excited to introduce advanced Microblading Removal services, providing patients with safe and effective solutions for unwanted or faded eyebrow tattoos.Microblading is a popular cosmetic procedure designed to enhance eyebrows by creating semi-permanent tattoos that mimic the look of natural brow hairs. However, over time, some individuals may seek to remove or lighten their microblading...

Read more

U.S. Investigator-Initiated Trial (IIT) to Evaluate Jaguar Health’s Crofelemer for Short Bowel Syndrome with Intestinal Failure (SBS-IF) Begins

December 6, 2024 8:30 AM

Jaguar Health, Inc. (NASDAQ:JAGX) (Jaguar) family company Napo Pharmaceuticals (Napo) today announced that an independent IIT in the U.S. to evaluate the efficacy and safety of crofelemer, Jaguar's novel plant-based anti-diarrheal prescription drug, for the rare disease indication of short bowel syndrome with intestinal failure (SBS-IF) in adults has begun. An overview of the study can be viewed on the ClinicalTrials.gov website.Lisa Conte,...

Read more

iZafe Group AB Strengthens Global Position with UMO Certification for Dosell

December 6, 2024 8:15 AM

iZafe Group (STO:IZAFE-B) announces that its product, Dosell, is now certified for integration with Enovation UMO, the monitoring solution for medical service centres. Enovation UMO is part of Enovation Platform, a leading platform for digital care and collaboration used in over 18 countries. This certification marks a significant milestone for iZafe and enables strategically important expansion in both established and new markets.A Long-Awaited...

Read more

Hemogenyx Pharmaceuticals PLC Announces CBR Macrophage Delivery Update

December 6, 2024 2:00 AM

LONDON, UK / ACCESSWIRE / December 6, 2024 / Hemogenyx Pharmaceuticals plc (LSE:HEMO), the clinical-stage biopharmaceutical company, is pleased to announce a breakthrough in its development of a novel method for delivering Chimeric Bait Receptors ("CBR") to innate immune cells such as macrophages and monocytes i.e. the white myeloid blood cells that make up the body's first line of defence against infections and responsible for the removal of...

Read more

Stemtech Corporation / Viago and Eevia Health Announce Proposed RTO

December 5, 2024 4:35 PM

Stemtech Corporation (OTCQB:STEK), a US-based company announced this past Tuesday its planned merger ("Merger") with Seacret Direct, LLC ("VIÁGO") and now announces a proposal for a Reverse Takeover (RTO) of Eevia Health Plc ("Eevia"), a Finnish producer of bioactive organic Arctic plant extracts and nutraceuticals and has its common stock listed on the Swedish Spotlight Stock Market under the symbol "EEVIA". This strategic RTO marks a major...

Read more

Champions Oncology to Announce Second Quarter Financial Results on Wednesday, December 11, 2024

December 5, 2024 4:30 PM

Champions Oncology, Inc. (NASDAQ:CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, will report its financial and operational results for the second quarter ended October 31, 2024, on Wednesday, December 11, 2024, after market close. The company will host a conference call to discuss the results that day at 4:30 P.M. EST (1:30 P.M. PST). To join the call dial 888-506-0062 (Domestic) or...

Read more

Dr. Heidi Kling's Groundbreaking Research and Practice in Eating Disorders and Antisocial Personality Disorder

December 5, 2024 3:15 PM

Dr. Heidi Kling, a renowned psychologist and expert in mental health, has cemented her reputation as a leading authority in understanding and addressing eating disorders and antisocial personality disorder (ASPD). With years of research and practice in these complex fields, Kling's work has been instrumental in transforming the way mental health professionals diagnose, treat, and approach individuals grappling with these challenging...

Read more

Birdsong Health Literacy Center of Excellence Launched to Advance Health Literacy and Drive Economic Prosperity

December 5, 2024 2:15 PM

NORFOLK, VA / ACCESSWIRE / December 5, 2024 / The newly established Birdsong Health Literacy Center of Excellence is set to make a transformative impact on the health of our nation by promoting health literacy, improving public health, empowering individuals, and driving economic prosperity through innovative community-based health education initiatives.The World Health Organization recently recognized health literacy as a stronger predictor of...

Read more

Merck Earns Top Spot on Newsweek’s List of America’s Most Responsible Companies 2025

December 5, 2024 1:45 PM

RAHWAY, NJ / ACCESSWIRE / December 5, 2024 / Merck (NYSE:MRK), known as MSD outside of the United States and Canada, has ranked No. 1 on Newsweek's annual list of America's Most Responsible Companies for the second year in a row."We hold ourselves to the highest standards of ethics and integrity," said Robert M. Davis, chairman and chief executive officer, Merck. "A firm belief in the importance of operating responsibly is at the heart of who we...

Read more

El Paso Medical Waste Disposal Company Addresses Increase in Needlestick Injuries With Key Guide

December 5, 2024 1:11 PM

EL PASO, TX / ACCESSWIRE / December 5, 2024 / With a rise in needlestick injuries becoming a significant concern, BioMedical Waste Solutions, a leading provider of medical waste disposal services, with locations in El Paso, TX, is proactively educating the community on the risks of improper disposal of medical waste, including needles.The CDC estimates that approximately 385,000 needlestick and sharps-related injuries occur each year among U.S....

Read more

Article about Canalevia-CA1, Jaguar Health's Prescription Drug Conditionally Approved by the FDA for the Treatment of Chemotherapy-Induced Diarrhea in Dogs, Published in PetVet Magazine

December 5, 2024 12:00 PM

Jaguar Health, Inc.(NASDAQ:JAGX) (Jaguar) today announced that an article about Canalevia-CA1 (crofelemer delayed-release tablets), Jaguar's prescription drug for the treatment of chemotherapy-induced diarrhea (CID) in dogs, has been published in PetVet Magazine and can be viewed by clicking here.Canalevia-CA1 is conditionally approved by the U.S. Food and Drug Administration for the treatment of CID in dogs and is the first and only treatment...

Read more

Travel Nurses, Inc. Announces Their 50th Daisy Award Honoree

December 5, 2024 11:00 AM

Travel Nurses, Inc. announced their fourth quarter DAISY Award recipients which marks the agency's 50th DAISY Award. Kourtney Chuman from Southport, North Carolina and Nicolette Kohler from Milford, Massachusetts were presented with this prestigious award earlier this quarter during a company-wide ceremony with the Travel Nurses, Inc. staff.The DAISY Award is an international program that recognizes the extraordinary skill and compassionate care...

Read more

Vituity Announces Enterprise-Wide Partnership With Clinical Documentation AI Leader Sayvant

December 5, 2024 11:00 AM

EMERYVILLE, CA / ACCESSWIRE / December 5, 2024 / Sayvant, the leader in clinical documentation AI for acute care settings, announced an enterprise-level agreement with Vituity. Vituity, a physician-owned and led multispecialty partnership with 6,000+ clinicians caring for more than 10 million patients annually, chose to expand its partnership with Sayvant after an extensive 12+ month co-development and design partnership led by Inflect Studio,...

Read more

CNS Pharmaceuticals to Host Virtual Analyst & Investor Day on December 11, 2024

December 5, 2024 9:10 AM

CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced it will host a Virtual Analyst & Investor Day on Wednesday, December 11th from 11:30 AM - 1:00 PM ET.For the event, John Climaco, Chief Executive Officer, Sandra Silberman, MD, PhD, Chief Medical Officer and...

Read more

THE SAVE, Written and Performed by Jack Merrill, is Now Playing at the Electric Lodge in Venice, California.

December 5, 2024 9:00 AM

VENICE, CA / ACCESSWIRE / December 5, 2024 / THE SAVE takes audiences on a journey from a seemingly privileged life in Evanston, Illinois, through a tumultuous childhood and into a harrowing abduction and escape from the notorious serial killer John Wayne Gacy.Merrill weaves together humor within the compelling dramatic moments and his straightforward honest approach and delivery has been regarded as akin to "Chicago Noir."PEOPLE Magazine...

Read more

Alter Behavioral Health: A 2024 Nominee for Best Residential Mental Health Treatment

December 5, 2024 9:00 AM

Alter Behavioral Health is thrilled to announce that the Santa Monica Daily Press (SMDP) has nominated it for the distinguished title of Best Residential Mental Health Treatment Center in 2024. This recognition highlights Alter's commitment to providing excellent, holistic care to individuals with mental health issues.Renowned for its personalized approach, Alter integrates evidence-based therapies such as Cognitive Behavioral Therapy (CBT),...

Read more

The Longevity Center Offering Low-Cost EBOO IV Therapy for a Wide Range of Health Conditions

December 5, 2024 9:00 AM

The Longevity Center, a health clinic located in West Palm Beach, Florida, specializing in regenerative, integrative, and osteopathic care, is providing patients with easy and affordable access to an extensive variety of alternative IV therapies - including Extracorporeal Blood Oxygenation and Ozonation (EBOO).EBOO, also referred to as EBo2, is an intravenous therapy intended to support immune and circulatory health and help manage pathogens...

Read more

Lucrative 2025 Healthcare IT Opportunities in 9 Emerging Global Markets Identified by Black Book Research

December 5, 2024 8:45 AM

Black Book Research has released a portion of its comprehensive annual study highlighting lucrative opportunities for electronic health record (EHR) and HIT vendors in markets with historically low adoption rates but significant growth potential. This landmark research, informed by insights from a multidisciplinary panel of global experts, examines market trends, adoption barriers, investment opportunities, and strategies to advance digital...

Read more

Sonoma Pharmaceuticals Successfully Transitions First Products to New EU MDR Requirements for Class IIb Medical Devices

December 5, 2024 8:30 AM

Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye, oral and nasal care, dermatological conditions, podiatry, and animal health care, today announced it has successfully completed transition to the new European Union (EU) Medical Device Regulation (MDR) for four...

Read more